Bio Essence Corporation (BIOE)
OTCMKTS · Delayed Price · Currency is USD
0.4000
0.00 (0.00%)
Apr 13, 2026, 9:30 AM EST

Bio Essence Statistics

Total Valuation

Bio Essence has a market cap or net worth of 15.20 million. The enterprise value is 16.77 million.

Market Cap15.20M
Enterprise Value 16.77M

Important Dates

The next estimated earnings date is Wednesday, May 13, 2026.

Earnings Date May 13, 2026
Ex-Dividend Date n/a

Share Statistics

Bio Essence has 38.01 million shares outstanding.

Current Share Class 38.01M
Shares Outstanding 38.01M
Shares Change (YoY) n/a
Shares Change (QoQ) n/a
Owned by Insiders (%) 90.49%
Owned by Institutions (%) n/a
Float 3.61M

Valuation Ratios

The trailing PE ratio is 16.96.

PE Ratio 16.96
Forward PE n/a
PS Ratio 8.01
PB Ratio -7.33
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio 9.69
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings 18.71
EV / Sales 8.84
EV / EBITDA 17.80
EV / EBIT 18.63
EV / FCF n/a

Financial Position

The company has a current ratio of 0.17

Current Ratio 0.17
Quick Ratio 0.01
Debt / Equity n/a
Debt / EBITDA 1.66
Debt / FCF n/a
Interest Coverage 411.72

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) 159.92%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) -44.63%
Weighted Average Cost of Capital (WACC) 54.58%
Revenue Per Employee 948,783
Profits Per Employee 448,099
Employee Count2
Asset Turnover 5.39
Inventory Turnover n/a

Taxes

In the past 12 months, Bio Essence has paid 800 in taxes.

Income Tax 800
Effective Tax Rate 0.09%

Stock Price Statistics

The stock price has increased by +86.92% in the last 52 weeks. The beta is 10.17, so Bio Essence's price volatility has been higher than the market average.

Beta (5Y) 10.17
52-Week Price Change +86.92%
50-Day Moving Average 0.11
200-Day Moving Average 0.85
Relative Strength Index (RSI) 78.77
Average Volume (20 Days) 16,957

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 0.41

Income Statement

In the last 12 months, Bio Essence had revenue of 1.90 million and earned 896,197 in profits. Earnings per share was 0.02.

Revenue1.90M
Gross Profit 1.43M
Operating Income 900,011
Pretax Income 896,997
Net Income 896,197
EBITDA 900,246
EBIT 900,011
Earnings Per Share (EPS) 0.02
Full Income Statement

Balance Sheet

Cash & Cash Equivalents n/a
Total Debt 1.56M
Net Cash -1.56M
Net Cash Per Share -0.04
Equity (Book Value) -2.07M
Book Value Per Share -0.05
Working Capital -2.02M
Full Balance Sheet

Cash Flow

Operating Cash Flow 1.57M
Capital Expenditures n/a
Depreciation & Amortization 235
Net Borrowing -1.57M
Free Cash Flow n/a
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 75.28%, with operating and profit margins of 47.43% and 47.23%.

Gross Margin 75.28%
Operating Margin 47.43%
Pretax Margin 47.27%
Profit Margin 47.23%
EBITDA Margin 47.44%
EBIT Margin 47.43%
FCF Margin n/a

Dividends & Yields

Bio Essence does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield 5.89%
FCF Yield n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Bio Essence has an Altman Z-Score of -24.31 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -24.31
Piotroski F-Score 7